The global Vaccines Market is estimated to be valued at USD 54.50 billion in 2025 and is projected to reach USD 111.3 billion ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

A new peer-reviewed study out of Turkey has raised questions about potential ocular side effects of the Pfizer-BioNTech COVID-19 vaccine, finding measurable structural changes to the cornea in ...

A new study suggests a potential link between the Pfizer COVID-19 vaccine and serious eye conditions like retinal vascular ...

TAMPA — Florida’s top health official blasted the manufacturer’s of mRNA COVID-19 vaccines and wants the federal government to do more to help those he described as the “vaccine injured.” Florida ...

When ticks bite us, they release thousands of proteins through their saliva. Could a vaccine for the right ones stop ticks ...

A team of researchers in Turkey have discovered multiple signs of stress in the eye after patients took Pfizer's COVID-19 vaccine. Long-term changes could have severe implications.

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

The existence of “magnetic nanoparticles” in COVID mRNA vaccines has raised significant concerns among scientists and public health advocates alike. A recent study conducted by reputable researchers ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

IBM and Moderna released research on Thursday advancing the use of quantum computing in the development of mRNA medicines, a ...